04:11 PM EDT, 06/05/2024 (MT Newswires) -- Percy H. Carter, Chief Scientific Officer, on June 03, 2024, sold 2,436 shares in Blueprint Medicines ( BPMC ) for $259,263. Following the Form 4 filing with the SEC, Carter has control over a total of 45,895 shares of the company, with 45,895 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1597264/000141588924015540/xslF345X03/form4-06052024_040602.xml